ACG signs memorandum of understanding with Applied DNA Sciences to develop molecularly tagged empty hard-shell capsules for pharmaceuticals and nutraceuticals.

Applied DNA Sciences, Inc. and ACG signed a memorandum of understanding (MoU) that will allow ACG to use Applied DNA’s SigNature^® molecular tagging and authentication technologies to develop molecularly tagged empty hard-shell capsules for offering to ACG’s customers to enhance product traceability and authentication. The MoU is expected to be followed by a definitive agreement.